Arissa Young

796 total citations
10 papers, 332 citations indexed

About

Arissa Young is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arissa Young has authored 10 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arissa Young's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Nutrition and Health in Aging (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Arissa Young is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Nutrition and Health in Aging (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Arissa Young collaborates with scholars based in United States, Australia and Chile. Arissa Young's co-authors include Douglas B. Johnson, Javid J. Moslehi, Elizabeth J. Davis, Henry T. Quach, Grant R. Williams, P. Brent Ferrell, Fei Ye, Bénédicte Lebrun‐Vignes, Kristin Kathleen Ancell and Joe‐Elie Salem and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and European Journal of Cancer.

In The Last Decade

Arissa Young

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arissa Young United States 7 214 84 57 50 50 10 332
Laetitia Coutte France 5 268 1.3× 61 0.7× 53 0.9× 46 0.9× 31 0.6× 10 386
Luciana Tanca Italy 7 158 0.7× 118 1.4× 69 1.2× 94 1.9× 39 0.8× 9 401
Pankti Reid United States 12 233 1.1× 60 0.7× 71 1.2× 30 0.6× 11 0.2× 42 358
Katerina Sfiridaki Greece 11 94 0.4× 55 0.7× 146 2.6× 90 1.8× 78 1.6× 17 376
Atsushi Isoda Japan 10 158 0.7× 54 0.6× 18 0.3× 96 1.9× 19 0.4× 27 321
Remi Sumiyoshi Japan 11 99 0.5× 105 1.3× 49 0.9× 52 1.0× 49 1.0× 50 359
J. Haney United States 5 121 0.6× 140 1.7× 131 2.3× 27 0.5× 16 0.3× 18 299
Vittorio Fregoni Italy 11 157 0.7× 32 0.4× 52 0.9× 173 3.5× 30 0.6× 23 383
Xiaojie Fang China 12 115 0.5× 38 0.5× 38 0.7× 20 0.4× 17 0.3× 52 329
Arzu Oğuz Türkiye 9 205 1.0× 24 0.3× 60 1.1× 32 0.6× 18 0.4× 36 310

Countries citing papers authored by Arissa Young

Since Specialization
Citations

This map shows the geographic impact of Arissa Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arissa Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arissa Young more than expected).

Fields of papers citing papers by Arissa Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arissa Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arissa Young. The network helps show where Arissa Young may publish in the future.

Co-authorship network of co-authors of Arissa Young

This figure shows the co-authorship network connecting the top 25 collaborators of Arissa Young. A scholar is included among the top collaborators of Arissa Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arissa Young. Arissa Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Andréasson, Kristofer, Arissa Young, Swapna Joshi, et al.. (2025). International Investigation of the Gut‐Lung Axis in Systemic Sclerosis–Interstitial Lung Disease. Arthritis Care & Research. 78(3). 352–361.
2.
Andréasson, Kristofer, Swapna Joshi, Jennifer S. Labus, et al.. (2024). POS0557 FECAL MICROBIOTA SIGNATURES OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: AN EXPLORATION OF THE GUT-LUNG AXIS IN AN INTERNATIONAL MULTICENTER STUDY. Annals of the Rheumatic Diseases. 83. 1030–1030. 1 indexed citations
3.
Young, Arissa, Brittany M. Rudy, & Elizabeth R. Volkmann. (2023). Living with Systemic Sclerosis: A Patient and Physician Perspective. Rheumatology and Therapy. 10(4). 785–792. 1 indexed citations
4.
Voss, Kelsey, Evan Krystofiak, Katherine N. Gibson‐Corley, et al.. (2023). Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus. Science Immunology. 8(79). eabq0178–eabq0178. 61 indexed citations
5.
6.
Young, Arissa, Henry T. Quach, Haocan Song, et al.. (2020). Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e000821–e000821. 73 indexed citations
7.
Davis, Elizabeth J., Joe‐Elie Salem, Arissa Young, et al.. (2019). Hematologic Complications of Immune Checkpoint Inhibitors. The Oncologist. 24(5). 584–588. 115 indexed citations
8.
Young, Arissa, Henry T. Quach, Elizabeth J. Davis, et al.. (2019). Impact of body composition on outcomes from anti-programmed death-1 (PD-1) treatment.. Journal of Clinical Oncology. 37(15_suppl). 9516–9516. 7 indexed citations
9.
Owen, C., James Larkin, Alexander N. Shoushtari, et al.. (2019). A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.. Journal of Clinical Oncology. 37(15_suppl). 9502–9502. 8 indexed citations
10.
Young, Arissa, Erin Weltzien, Marilyn L. Kwan, et al.. (2014). Pre- to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. Journal of Cancer Survivorship. 8(4). 539–547. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026